{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:11:56Z","timestamp":1791670316651,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2008500"],"award-info":[{"award-number":["2020YFC2008500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071216"],"award-info":[{"award-number":["82071216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901171"],"award-info":[{"award-number":["81901171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971029"],"award-info":[{"award-number":["81971029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014215","name":"Huxiang Youth Talent Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014215","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>The relationships between multiple visual rating scales based on structural magnetic resonance imaging (sMRI) with disease severity and cerebrospinal fluid (CSF) biomarkers in patients with Alzheimer\u2019s disease (AD) were ambiguous. In this study, a total of 438 patients with clinically diagnosed AD were recruited. All participants underwent brain sMRI scan, and medial temporal lobe atrophy (MTA), posterior atrophy (PA), global cerebral atrophy-frontal sub-scale (GCA-F), and Fazekas rating scores were visually evaluated. Meanwhile, disease severity was assessed by neuropsychological tests such as the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and Clinical Dementia Rating (CDR). Among them, 95 patients were tested for CSF core biomarkers, including A\u03b2<jats:sub>1\u201342<\/jats:sub>, A\u03b2<jats:sub>1\u201340<\/jats:sub>, A\u03b2<jats:sub>1\u201342\/<\/jats:sub>A\u03b2<jats:sub>1\u201340<\/jats:sub>, p-tau, and t-tau. As a result, the GCA-F and Fazekas scales showed positively significant correlations with onset age (<jats:italic>r<\/jats:italic> = 0.181, <jats:italic>p<\/jats:italic> &amp;lt; 0.001; <jats:italic>r<\/jats:italic> = 0.411, <jats:italic>p<\/jats:italic> &amp;lt; 0.001, respectively). Patients with late-onset AD (LOAD) showed higher GCA-F and Fazekas scores (<jats:italic>p<\/jats:italic> &amp;lt; 0.001, <jats:italic>p<\/jats:italic> &amp;lt; 0.001). With regard to the disease duration, the MTA and GCA-F were positively correlated (<jats:italic>r<\/jats:italic> = 0.137, <jats:italic>p<\/jats:italic> &amp;lt; 0.05; <jats:italic>r<\/jats:italic> = 0.106, <jats:italic>p<\/jats:italic> &amp;lt; 0.05, respectively). In terms of disease severity, a positively significant association emerged between disease severity and the MTA, PA GCA-F, and Fazekas scores (<jats:italic>p<\/jats:italic> &amp;lt; 0.001, <jats:italic>p<\/jats:italic> &amp;lt; 0.001, <jats:italic>p<\/jats:italic> &amp;lt; 0.001, <jats:italic>p<\/jats:italic> &amp;lt; 0.05, respectively). Moreover, after adjusting for age, gender, and <jats:italic>APOE<\/jats:italic> alleles, the MTA scale contributed to moderate to severe AD in statistical significance independently by multivariate logistic regression analysis (<jats:italic>p<\/jats:italic> &amp;lt; 0.05). The model combining visual rating scales, age, gender, and <jats:italic>APOE<\/jats:italic> alleles showed the best performance for the prediction of moderate to severe AD significantly (AUC = 0.712, sensitivity = 51.5%, specificity = 84.6%). In addition, we observed that the MTA and Fazekas scores were associated with a lower concentration of A\u03b2<jats:sub>1\u201342<\/jats:sub> (<jats:italic>p<\/jats:italic> &amp;lt; 0.031, <jats:italic>p<\/jats:italic> &amp;lt; 0.022, respectively). In summary, we systematically analyzed the benefits of multiple visual rating scales in predicting the clinical status of AD. The visual rating scales combined with age, gender, and <jats:italic>APOE<\/jats:italic> alleles showed best performance in predicting the severity of AD. MRI biomarkers in combination with CSF biomarkers can be used in clinical practice.<\/jats:p>","DOI":"10.3389\/fnagi.2022.906519","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T05:54:13Z","timestamp":1659074053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"14","author":[{"given":"Mei-dan","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-wen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-ling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-sha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-feng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.nicl.2020.102333","article-title":"The combined effect of amyloid-\u03b2 and tau biomarkers on brain atrophy in dementia with Lewy bodies.","volume":"27","author":"Abdelnour","year":"2020","journal-title":"NeuroImage. Clini."},{"key":"B2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2020.11.015","article-title":"A multilevel view of the development of Alzheimer\u2019s Disease.","volume":"457","author":"Avila","year":"2021","journal-title":"Neuroscience"},{"key":"B3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41591-020-0797-4","article-title":"Another step forward in blood-based diagnostics for Alzheimer\u2019s disease.","volume":"26","author":"Bateman","year":"2020","journal-title":"Nat. Med."},{"key":"B4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/brain\/awaa068","article-title":"Medial temporal lobe connectivity and its associations with cognition in early Alzheimer\u2019s disease.","volume":"143","author":"Berron","year":"2020","journal-title":"Brain"},{"key":"B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13195-017-0328-9","article-title":"Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline.","volume":"9","author":"Bos","year":"2017","journal-title":"Alzheimer\u2019s Res, Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00330-020-07196-8","article-title":"Automated age- and sex-specific volumetric estimation of regional brain atrophy: workflow and feasibility.","volume":"31","author":"Caspers","year":"2021","journal-title":"Eur. Radiol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","article-title":"Magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment.","volume":"266","author":"Chandra","year":"2019","journal-title":"J. Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s00330-016-4726-3","article-title":"Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer\u2019s disease: validation in a large memory clinic population.","volume":"27","author":"Claus","year":"2017","journal-title":"Eur. Radiol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2022.3151118","article-title":"TR-Gan: multi-session future MRI prediction with temporal recurrent generative adversarial Network","author":"Fan","year":"2022","journal-title":"IEEE Transactions on Medical Imaging"},{"key":"B10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"Mr signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging.","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am. J. Roentgenol."},{"key":"B11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12358","article-title":"Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer\u2019s disease and mild cognitive impairment.","volume":"278","author":"Ferreira","year":"2015","journal-title":"J. Int. Med."},{"key":"B12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine.","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.3174\/ajnr.A1059","article-title":"Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment.","volume":"29","author":"Fjell","year":"2008","journal-title":"Am. J. Neuroradiol."},{"key":"B14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.2005.082651","article-title":"Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment.","volume":"77","author":"Geroldi","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B15","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1073\/pnas.1815917116","article-title":"Persistent metabolic youth in the aging female brain.","volume":"116","author":"Goyal","year":"2019","journal-title":"Proc. Nal. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1136\/jnnp-2014-310090","article-title":"Using visual rating to diagnose dementia: a critical evaluation of Mri atrophy scales.","volume":"86","author":"Harper","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/brain\/aww005","article-title":"Mri visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.","volume":"139","author":"Harper","year":"2016","journal-title":"Brain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.media.2020.101850","article-title":"Multi-scale graph-based grading for Alzheimer\u2019s disease prediction.","volume":"67","author":"Hett","year":"2021","journal-title":"Med. Image Anal."},{"key":"B19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"Nia-Aa research framework: toward a biological definition of Alzheimer\u2019s disease.","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"B20","doi-asserted-by":"publisher","first-page":"749649","DOI":"10.3389\/fnagi.2021.749649","article-title":"Performance of plasma amyloid \u03b2, total tau, and neurofilament light chain in the identification of probable Alzheimer\u2019s Disease in South China.","volume":"13","author":"Jiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2422.e9","DOI":"10.1016\/j.neurobiolaging.2014.04.025","article-title":"Investigation of Trem2, Pld3, and Unc5C variants in patients with Alzheimer\u2019s disease from mainland China.","volume":"35","author":"Jiao","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.14283\/jpad.2018.5","article-title":"Correlation of Csf- and Mri-biomarkers and progression of cognitive decline in an open label mci trial.","volume":"5","author":"Joachim","year":"2018","journal-title":"J. Prevention Alzheimer\u2019s Dis."},{"key":"B23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/jcm8020167","article-title":"White Matter changes in patients with Alzheimer\u2019s Disease and associated factors.","volume":"8","author":"Kao","year":"2019","journal-title":"J. Clin. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3233\/jad-2005-8106","article-title":"Asynchronous regional brain volume losses in presymptomatic to moderate Ad.","volume":"8","author":"Kaye","year":"2005","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s Disease.","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","article-title":"Visual assessment of posterior atrophy development of a Mri rating scale.","volume":"21","author":"Koedam","year":"2011","journal-title":"Eur. Radiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neurobiolaging.2012.03.010","article-title":"Visual ratings of atrophy in Mci: prediction of conversion and relationship with Csf biomarkers.","volume":"34","author":"Lehmann","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp-2014-310095","article-title":"Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies.","volume":"87","author":"Li","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-210344","article-title":"Relationship between general cognition, visual assessed cortical atrophy, and cerebrospinal fluid biomarkers in Alzheimer\u2019s Disease: a cross-sectional study from a Chinese pumch cohort.","volume":"82","author":"Mao","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"102310","DOI":"10.1016\/j.nicl.2020.102310","article-title":"Medial temporal atrophy in preclinical dementia: visual and automated assessment during six year follow-up.","volume":"27","author":"M\u00e5rtensson","year":"2020","journal-title":"NeuroImage. Clin."},{"key":"B31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","article-title":"Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.","volume":"134","author":"McAleese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"Csf and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet. Neurol."},{"key":"B33","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.1007\/s00330-021-08227-8","article-title":"Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer\u2019s disease: a systematic review and meta-analysis.","volume":"31","author":"Park","year":"2021","journal-title":"Eur. Radiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3233\/JAD-2009-1117","article-title":"Education attenuates the effect of medial temporal lobe atrophy on cognitive function in Alzheimer\u2019s disease: the Mirage study.","volume":"17","author":"Perneczky","year":"2009","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/jnnp-2017-316603","article-title":"Csf \u03b2-amyloid and white matter damage: a new perspective on Alzheimer\u2019s disease.","volume":"89","author":"Pietroboni","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2017.05.014","article-title":"Untangling GENETIC RISK FOR Alzheimer\u2019s Disease.","volume":"83","author":"Pimenova","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"B37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.01.009","article-title":"Heterogeneous patterns of brain atrophy in Alzheimer\u2019s disease.","volume":"65","author":"Poulakis","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"B38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13195-017-0326-y","article-title":"Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment.","volume":"9","author":"Pyun","year":"2017","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fnagi.2017.00117","article-title":"MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis.","volume":"9","author":"Rhodius-Meester","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1212\/01.WNL.0000148602.30175.AC","article-title":"Atrophy rate in medial temporal lobe during progression of Alzheimer disease.","volume":"63","author":"Rusinek","year":"2004","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e12244","DOI":"10.1002\/dad2.12244","article-title":"Brain atrophy trajectories predict differential functional performance in Alzheimer\u2019s disease: moderations with apolipoprotein E and sex.","volume":"13","author":"Sapkota","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"B42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","article-title":"Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.","volume":"1","author":"Scheltens","year":"2002","journal-title":"Lancet. Neurol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on Mri in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates.","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000117417","article-title":"Qualitative assessment of cerebral atrophy on Mri: inter- and intra-observer reproducibility in dementia and normal aging.","volume":"37","author":"Scheltens","year":"1997","journal-title":"Eur. Neurol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neurobiolaging.2006.11.018","article-title":"Csf and Mri markers independently contribute to the diagnosis of Alzheimer\u2019s disease.","volume":"29","author":"Schoonenboom","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"Mri of hippocampal volume loss in early Alzheimer\u2019s disease in relation to ApoE genotype and biomarkers.","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","article-title":"A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer\u2019s disease severity.","volume":"11","author":"Schwarz","year":"2016","journal-title":"NeuroImage Clin."},{"key":"B48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-200016","article-title":"Combining visual rating scales for medial temporal lobe atrophy and posterior atrophy to identify amnestic mild cognitive impairment from cognitively normal older adults: evidence based on two cohorts.","volume":"77","author":"Sheng","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2174\/1567205017666200807193957","article-title":"The parietal atrophy score on brain magnetic resonance imaging is a reliable visual scale.","volume":"17","author":"Silhan","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3233\/JAD-210372","article-title":"Hippocampo-horn percentage and parietal atrophy score for easy visual assessment of brain atrophy on magnetic resonance imaging in early- and late-onset Alzheimer\u2019s Disease.","volume":"84","author":"Silhan","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1212\/01.wnl.0000311446.61861.e3","article-title":"Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.","volume":"70","author":"Sluimer","year":"2008","journal-title":"Neurology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1600-0404.2008.01045.x","article-title":"White matter lesion severity is associated with reduced cognitive performances in patients with normal Csf Abeta42 levels.","volume":"118","author":"Stenset","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"B53","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/WNL.0b013e3182704056","article-title":"Injury markers predict time to dementia in subjects with Mci and amyloid pathology.","volume":"79","author":"Van Rossum","year":"2012","journal-title":"Neurology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11064-021-03448-1","article-title":"Research progress on mechanism of neuroprotective roles of Apelin-13 in prevention and treatment of Alzheimer\u2019s Disease.","volume":"47","author":"Wan","year":"2022","journal-title":"Neurochem. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12877-019-1072-8","article-title":"A new age-related cutoff of medial temporal atrophy scale on Mri improving the diagnostic accuracy of neurodegeneration due to Alzheimer\u2019s disease in a Chinese population.","volume":"19","author":"Wei","year":"2019","journal-title":"BMC Geriatr."},{"key":"B56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fneur.2019.00093","article-title":"Multiple visual rating scales based on structural mri and a novel prediction model combining visual rating scales and age stratification in the diagnosis of Alzheimer\u2019s Disease in the Chinese population.","volume":"10","author":"Yuan","year":"2019"},{"key":"B57","doi-asserted-by":"publisher","first-page":"106676","DOI":"10.1016\/j.cmpb.2022.106676","article-title":"Bpgan: brain pet synthesis from MRI using generative adversarial network for multi-modal Alzheimer\u2019s disease diagnosis.","volume":"217","author":"Zhang","year":"2022","journal-title":"Comput. Methods Programs Biomed."},{"key":"B58","doi-asserted-by":"publisher","first-page":"779344","DOI":"10.3389\/fneur.2021.779344","article-title":"Characteristics of cortical atrophy and white matter lesions between dementia with lewy bodies and alzheimer\u2019s disease: a case-control study.","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Neurol."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.906519\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T05:54:44Z","timestamp":1659074084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.906519\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":58,"alternative-id":["10.3389\/fnagi.2022.906519"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.906519","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"article-number":"906519"}}